The New York Stock Exchange announced that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common stock of Danimer Scientific (DNMR) – ticker symbol DNMR – from the NYSE. Trading in the company’s Class A common stock will be suspended immediately. NYSE Regulation reached its decision to delist the company’s Class A common stock because the company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000. The company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the company’s Class A common stock upon completion of all applicable procedures, including any appeal by the company of the NYSE Regulation staff’s decision.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNMR: